These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of vascular leakage in acute Kawasaki disease. Terai M; Honda T; Yasukawa K; Higashi K; Hamada H; Kohno Y Circulation; 2003 Jul; 108(3):325-30. PubMed ID: 12835221 [TBL] [Abstract][Full Text] [Related]
4. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196 [TBL] [Abstract][Full Text] [Related]
5. [Changes of P-selectin and E-selectin in children with Kawasaki disease]. Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673 [TBL] [Abstract][Full Text] [Related]
6. Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease. Takeshita S; Kawamura Y; Takabayashi H; Yoshida N; Nonoyama S Clin Exp Immunol; 2005 Mar; 139(3):575-9. PubMed ID: 15730405 [TBL] [Abstract][Full Text] [Related]
7. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Ohno T; Yuge T; Kariyazono H; Igarashi H; Joh-o K; Kinugawa N; Kusuhara K; Hara T Eur J Pediatr; 2002 Feb; 161(2):105-11. PubMed ID: 11954744 [TBL] [Abstract][Full Text] [Related]
8. Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. Breunis WB; Davila S; Shimizu C; Oharaseki T; Takahashi K; van Houdt M; Khor CC; Wright VJ; Levin M; Burns JC; Burgner D; Hibberd ML; Kuijpers TW; Arthritis Rheum; 2012 Jan; 64(1):306-15. PubMed ID: 21905000 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor in acute Kawasaki disease. Terai M; Yasukawa K; Narumoto S; Tateno S; Oana S; Kohno Y Am J Cardiol; 1999 Feb; 83(3):337-9. PubMed ID: 10072219 [TBL] [Abstract][Full Text] [Related]
10. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease. Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520 [TBL] [Abstract][Full Text] [Related]
11. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. Yasukawa K; Terai M; Shulman ST; Toyozaki T; Yajima S; Kohno Y; Rowley AH Circulation; 2002 Feb; 105(6):766-9. PubMed ID: 11839635 [TBL] [Abstract][Full Text] [Related]
12. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions]. Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276 [TBL] [Abstract][Full Text] [Related]
13. Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome. Ueno K; Nomura Y; Hashiguchi T; Masuda K; Morita Y; Hazeki D; Eguchi T; Maruyama I; Kawano Y Br J Haematol; 2010 Jan; 148(2):285-92. PubMed ID: 19793253 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Zhao J; Hu J; Cai J; Yang X; Yang Z Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699 [TBL] [Abstract][Full Text] [Related]
16. Circulating vascular endothelial growth factor in patients with colorectal cancer. Fujisaki K; Mitsuyama K; Toyonaga A; Matsuo K; Tanikawa K Am J Gastroenterol; 1998 Feb; 93(2):249-52. PubMed ID: 9468253 [TBL] [Abstract][Full Text] [Related]
17. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma. Shang ZJ; Li JR; Li ZB Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564 [TBL] [Abstract][Full Text] [Related]
18. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors? Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245 [TBL] [Abstract][Full Text] [Related]
19. [Significance of vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma]. Zhao J; Hu J; Cai J Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):389-92. PubMed ID: 11810769 [TBL] [Abstract][Full Text] [Related]
20. Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease. Ebata R; Abe J; Yasukawa K; Hamada H; Higashi K; Suwazono Y; Saito H; Terai M; Kohno Y Circ J; 2011; 75(6):1455-62. PubMed ID: 21483160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]